February 7, 2025- BD announced results for its fiscal 2025 first quarter which ended December 31, 2024. Recent highlights include that the company announced the BD board authorized the repurchase of up to 10 million shares of BD common stock in addition to the shares that remain available under the board’s previous authorization in 2021.
BD Medical:
- The Medication Delivery Solutions business unit announced:
- Additional investments in its U.S. manufacturing network to add capacity for critical medical devices, including syringes, needles and IV catheters, to meet the ongoing needs of the nation’s health care system.
- Carilion Clinic is the first health system in Virginia to offer needle-free in-patient blood draws using the BD® PIVO™ Pro Needle-free Blood Collection Device, redefining the standard of care for patients and delivering on the vision of a “One-Stick Patient Experience.”